WHO ICTRP trial

Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and…

ChiCTR2400089762 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2400089762
Public title Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of Longkoma Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) Implanted in Populations of 6 Weeks and Older
Scientific title Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of Longkoma Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) Implanted in Populations of 6 Weeks and Older
Primary sponsor Guangxi Zhuang Autonomous Region Centre for Disease Control and Prevention
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 1-2
Countries China
Conditions Acute gastroenteritis caused by norovirus
Interventions adults:low dose;adults:high dose;adults:Placebo (with aluminum);teenagers:low dose;teenagers:high dose;teenagers:Placebo (with aluminum);elderly(60 years old and above):low dose;elderly(60 years old and above):high dose;elderly(60 years old…
Registration date Sep 14, 2024
Target size adults:20;adults:20;adults:20;teenagers:20;teenagers:20;teenagers:20;elderly(60…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations